Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
India auto hub lets car plants run at full capacity despite few vaccinations – Reuters
Article feature image
First US trial cruise testing Covid safety protocols to set sail on Sunday – CNN
Article feature image
Texas energy companies remotely raised smart thermostats temperatures – Business Insider